The European Journal of Neurology reported that 'Misfolded alpha‐synuclein in amyotrophic lateral sclerosis' was "ranked within the top 10% of most viewed papers" published in their journal. See link.

See paper 'Misfolded alpha‐synuclein in amyotrophic lateral sclerosis: Implications for diagnosis and treatment' here: https://onlinelibrary.wiley.com/doi/10.1111/ene.16206

New York Times Publishes "Tofersen, a New Treatment for ALS"

Find the article here.

Dr. Smith & Dr. Stokin, scientific advisor to CNS, spoke about neurodegenerative disease and drug discovery at the Vienna BioCenter

3/31/2026